← Back to Clinical Trials
Recruiting NCT06558409

NCT06558409 Safer Still (Exploratory Project 3)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06558409
Status Recruiting
Phase
Sponsor Jeff Bridge
Condition Suicide Prevention
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2024-11-07
Primary Completion 2027-07-31

Trial Parameters

Condition Suicide Prevention
Sponsor Jeff Bridge
Study Type INTERVENTIONAL
Phase N/A
Enrollment 80
Sex ALL
Min Age 18 Years
Max Age 90 Years
Start Date 2024-11-07
Completion 2027-07-31
Interventions
" Safer Still " Interactive InterventionEnhanced Usual Care (EUC):

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The long-term goal is to decrease suicide and suicidal behaviors in at-risk youth through preventative interventions. Investigators propose to develop an interactive intervention ("Safer Still") to help promote safe storage of firearms during the critical period immediately following high-risk care transitions. The objective of this study is to develop and test the Safer Still intervention as an efficient adjunct to traditional care for adolescents aged 12-17 years who are discharged from psychiatric hospitals and living in households where firearms are stored unsafely.

Eligibility Criteria

Inclusion Criteria: * Parent or legal guardian of an adolescent aged 12 to 17 years at time of consent * Have a child who is receiving psychiatric inpatient, crisis, or emergency treatment at Nationwide Children's Hospital * Indicate that at least one firearm is located in or around the residence of the adolescent and is stored unlocked, loaded, or both unlocked and loaded. * Only one parent per household is permitted to participate to avoid contamination across the two study conditions. Exclusion Criteria: * Inability to speak/read English * Lack access to a digital device (smartphone, iPad, tablet computer, desktop, laptop PC).

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology